A struggling mid-cap I’d dump for this FTSE 100 dividend stock yielding 9%!

This FTSE 100 (INDEXFTSE:UKX) offers one of the best dividend yields around. It’s time to take advantage says Rupert Hargreaves. But what to buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in financial services group Just (LSE: JUST) currently look like a steal. The stock is trading at a forward P/E ratio of just 3.5 and a price to tangible book value of 0.3.

However, the stock is cheap for a reason. Just is a significant provider of so-called lifetime mortgages. These products allow retirees to take out equity from the value of their homes, which they can then use to cover living expenses. When they pass away, Just uses proceeds from the sale of the house to recoup its initial investment plus interest.

Regulators have these products in the crosshairs because they believe companies could be taking on more risk than is acceptable. A sudden fall in home prices could destabilise the entire model and leave businesses like Just out of pocket. 

Should you invest £1,000 in Aviva right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Aviva made the list?

See the 6 stocks

Taking action

Management has been trying to reassure investors that it has the situation under control by improving its capital ratios. But these efforts are being hampered by falling levels of business. According to the company’s trading update for the first six months of 2019, underlying profit declined 27%, and new business operating profit declined 39%.

In its update, the business also says it is reducing “new business strain” and is reducing “Defined Benefit longevity risk through reinsurance.” These actions have helped improve Just’s capital position, but the company is also warning that it might have to raise additional funds.

All in all, there are just so many moving parts here, I think it’s probably best for investors to avoid Just entirely (although my Foolish colleague Harvey Jones seems to disagree). 

There are many other companies out there on the market that offer a better risk-reward profile, one of which is FTSE 100 dividend champion Aviva (LSE: AV).

A bigger, better buy

Just and Aviva operate in basically the same market, but Aviva has size on its side. 

The group is also well-diversified with operations around the world. More importantly, it also has a much stronger balance sheet. 

Indeed, at the end of 2018, Aviva reported a Solvency II capital surplus of £12bn with a Solvency II cover ratio of 204%. At the end of June, Just’s Solvency II cover ratio was only 149%. 

Balance sheet strength isn’t the only difference between these two companies. Aviva is also far more profitable. Just has reported losses in two of the past six years. During the same time frame, Aviva has reported a cumulative net income of more than £7bn. 

As the numbers above show, Aviva is a much stronger business than its smaller peer, but despite its attractive fundamentals, the stock is currently trading at a bargain-basement forward P/E of just six. City analysts have pencilled in earnings per share growth of 69% this year following an increase of 4% in 2018 and 84% in 2017.

Analysts are also expecting the company to announce a full-year dividend of 31.1p, giving a forward dividend yield of 8.3% at current prices. In my opinion, this valuation is too good to pass up. That’s why I’d avoid shares in Just and buy Aviva instead. The larger business has much more attractive fundamentals.

Investing in AI: 3 Stocks with Huge Potential!

🤖 Are you fascinated by the potential of AI? 🤖

Imagine investing in cutting-edge technology just once, then watching as it evolves and grows, transforming industries and potentially even yielding substantial returns.

If the idea of being part of the AI revolution excites you, along with the prospect of significant potential gains on your initial investment…

Then you won't want to miss this special report inside Motley Fool Share Advisor – 'AI Front Runners: 3 Surprising Stocks Riding The AI Wave’!

And today, we're giving you exclusive access to ONE of these top AI stock picks, absolutely free!

Get your free AI stock pick

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Hunting for an enticing entry point? 3 US stocks to key an eye on

As financial markets remain turbulent, savvy investors are hunting for opportunities in the chaos. I have quite an extensive watchlist…

Read more »

Investing Articles

Is it still a good time to buy shares?

With the US announcing smartphones, computers, and semiconductors from China are exempt from certain tariffs, is it safe to buy…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

After a 10% drop in this FTSE gem, investors could target £6,250 in yearly passive income from an £11,000 stake!

This FTSE 100 financial heavyweight has a high yield that can generate serious passive income over time and it also…

Read more »

Investing Articles

BAE Systems’ share price has bounced back from Trump’s tariffs, so is there still enough value for me to buy more?

BAE Systems’ share price fell after the US’s tariffs statement but has recovered to near a 12-month high. So, is…

Read more »

Investing Articles

Up 60%? See the stunning IAG share price forecast for 2025!

The IAG share price has been hugely volatile and Harvey Jones says that looks set to continue. But there are…

Read more »

The words "what's your plan for retirement" written on chalkboard on pavement somewhere in London
Investing Articles

Worried about retirement? Even at 40, £300 a month in a Stocks and Shares ISA can build wealth

Even when starting late, investing a few hundred pounds a month in a Stocks and Shares ISA can build into…

Read more »

Investing Articles

£10,000 invested in Barclays shares 10 years ago is now worth…

City analysts think Barclays shares could be primed for lift-off. But how realistic are price targets for the FTSE 100…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Dividend Shares

Were we right to ditch our GSK shares?

In spring 2021, my family sold a big lump of GSK shares. Four years later, we have no regrets. Indeed,…

Read more »